DCN and neoplasm: Decorin binds with high affinity to various receptor tyrosine kinases including Met, EGFR, IGF-IR, PDGFR, and VEGFR2, to induce a multitude of oncosuppressive functions, including the inhibition of tumor growth and progression (Bi et al., 2008; Horváth et al., 2014).